White House

Hospitals By Bob Herman

New Jersey hospitals scrap merger after FTC challenge

Exclusive By Rachel Cohrs

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Politics By Lev Facher

Francis Collins on his new life as White House science adviser

Hospitals By Tara Bannow

The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it

Politics By Nicholas Florko and Rachel Cohrs

AbbVie dramatically boosts its spending on lobbying

D.C. Diagnosis By Nicholas Florko

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

Politics By Nicholas Florko

Flagship Pioneering hires lobbyists, a first among biotech venture firms

Politics By Lev Facher

The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years

Exclusive By Rachel Cohrs

White House documents detail a looming squeeze on Covid-19 boosters

Exclusive By Nicholas Florko

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Health By Megan Molteni

Covid’s circling the White House. What are the risks to someone like Biden?

Politics By Rachel Cohrs

Manchin won’t support new health policy unless Congress rolls back Trump tax cuts

D.C. Diagnosis By Nicholas Florko

The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle

Exclusive By Rachel Cohrs

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

Politics By Lev Facher

A new nonprofit wants to rewrite the playbook for how the U.S. government funds science

D.C. Diagnosis By Nicholas Florko

Biogen’s head-scratching new lobbyist hire

Politics By Lev Facher

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

Politics By Rachel Cohrs

Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers

Politics By Rachel Cohrs

Biden administration ramps up long Covid research efforts following criticism

Politics By Lev Facher

‘All the shrapnel that’s in my back’: Defiant Robert Redfield blasts former CDC directors for criticism during Covid-19

D.C. Diagnosis By Nicholas Florko

Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

Politics By Rachel Cohrs

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Exclusive By Lev Facher

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

Politics By Rachel Cohrs

CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine

Exclusive By Lev Facher

Most Read

‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19

Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’

How the Covid-19 pandemic prepared the White House to respond to monkeypox

Justice Department says sweeping lab test fraud in Texas involved dozens of doctors and front companies

Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug

A no good, very bad week for the FDA

AstraZeneca’s ambitious vaccine dreams are finally, officially dead

What happens when the government stops buying Covid-19 vaccines?

All Coverage

New Jersey hospitals scrap merger after FTC challenge

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Francis Collins on his new life as White House science adviser

The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it

AbbVie dramatically boosts its spending on lobbying

As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms

Flagship Pioneering hires lobbyists, a first among biotech venture firms

The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years

White House documents detail a looming squeeze on Covid-19 boosters

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Covid’s circling the White House. What are the risks to someone like Biden?

Manchin won’t support new health policy unless Congress rolls back Trump tax cuts

The FDA’s ban on menthol in cigarettes clears a major regulatory hurdle

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

A new nonprofit wants to rewrite the playbook for how the U.S. government funds science

Biogen’s head-scratching new lobbyist hire

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers

Biden administration ramps up long Covid research efforts following criticism

‘All the shrapnel that’s in my back’: Defiant Robert Redfield blasts former CDC directors for criticism during Covid-19

Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy

Senate nears $10 billion deal to buy Covid vaccines, therapeutics

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Subscribe to STAT for $15 per month lorem ipsum